Advanced search
Publication Cover
Journal of Medical Economics Volume 6, 2003 - Issue 1-4
Submit an article Journal homepage
210
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Comparisons of efficacy and cost-effectiveness of topical immunomodulators in the management of atopic dermatitis

William Abramovits Baylor University Medical Center and University of Texas Southwestern School of Medicine, Dallas, Texas, USA
, MD,
Mark Boguniewicz National Jewish Medical and Research Center, Denver, Colorado, USA
, MD,
Mary M Prendergast Fujisawa Healthcare, Inc., Deerfield, Illinios, USA
, MBA,
Michael Tokar Quorum Consulting, Inc., San Francisco, California, USA
, MS &
Kuo B Tong Quorum Consulting, Inc., San Francisco, California, USACorrespondence[email protected]
, MS
Pages 1-14 | Accepted 20 Nov 2002, Published online: 02 Dec 2008

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mandy Gutknecht, Rabea Reinert & Matthias Augustin. (2019) Review of health economic analyses in atopic dermatitis: how diverse is the literature?. Expert Review of Pharmacoeconomics & Outcomes Research 19:2, pages 127-145.
Read now

Articles from other publishers (13)

T.H. Sach, E. McManus & N.J. Levell. (2019) Understanding economic evidence for the prevention and treatment of atopic eczema. British Journal of Dermatology 181:4, pages 707-716.
Crossref
Emma McManus, Tracey Sach & Nick Levell. (2017) The Use of Decision–Analytic Models in Atopic Eczema: A Systematic Review and Critical Appraisal. PharmacoEconomics 36:1, pages 51-66.
Crossref
Brian Keng Yong Chia & Hong Liang Tey. (2015) Systematic Review on the Efficacy, Safety, and Cost-Effectiveness of Topical Calcineurin Inhibitors in Atopic Dermatitis. Dermatitis 26:3, pages 122-132.
Crossref
Lily P.H. Yang & Monique P. Curran. (2010) Spotlight on Topical Pimecrolimus in Pediatric Atopic Dermatitis†. American Journal of Clinical Dermatology 11:4, pages 295-298.
Crossref
Lily P.H. Yang & Monique P. Curran. (2009) Topical Pimecrolimus. Pediatric Drugs 11:6, pages 407-426.
Crossref
Anthony J. Mancini, Kellee Kaulback & Sarah L. Chamlin. (2008) The Socioeconomic Impact of Atopic Dermatitis in the United States: A Systematic Review. Pediatric Dermatology 25:1, pages 1-6.
Crossref
J. Hjelmgren, Å. Svensson, E.T. Jörgensen, B. Lindemalm-Lundstam & G. Ragnarson Tennvall. (2007) Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data. British Journal of Dermatology 156:5, pages 913-921.
Crossref
William Abramovits, Peter Hung & Kuo B Tong. (2006) Efficacy and Economics of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis. American Journal of Clinical Dermatology 7:4, pages 213-222.
Crossref
William Abramovits. (2005) A clinician's paradigm in the treatment of atopic dermatitis. Journal of the American Academy of Dermatology 53:1, pages S70-S77.
Crossref
Ulrich Hengge & Thomas Ruzicka. (2005) Topische Calcineurin-Inhibitoren in der Dermatologie: Effektive und nebenwirkungsarme Therapie. Pharmazie in unserer Zeit 34:4, pages 314-320.
Crossref
William Abramovits, Mark Boguniewicz, Amy S Paller, Diane L Whitaker-Worth, Mary M Prendergast, Michael Tokar & Kuo B Tong. (2005) The Economics of Topical Immunomodulators for the Treatment of Atopic Dermatitis. PharmacoEconomics 23:6, pages 543-566.
Crossref
A. Alomar, J. Berth-Jones, J.D. Bos, A. Giannetti, S. Reitamo, T. Ruzicka, J-F. Stalder & K. Thestrup-Pedersen. (2004) The role of topical calcineurin inhibitors in atopic dermatitis:. British Journal of Dermatology 151:s70, pages 3-27.
Crossref
M. Augustin. 2004. Tacrolimus Ointment. Tacrolimus Ointment 255 270 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.